Tissue Levels of WR-1065, the Active Metabolite of Amifostine (Ethyol<sup>®</sup>), Are Equivalent following Intravenous or Subcutaneous Administration in Cynomolgus Monkeys-Reference-Cited by-同舟云学术

Tissue Levels of WR-1065, the Active Metabolite of Amifostine (Ethyol^®), Are Equivalent following Intravenous or Subcutaneous Administration in Cynomolgus Monkeys

Published:2004 Issue:3-4 Volume:67 Page:187-193
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Bachy Christine M.,Fazenbaker Christine A.,Kifle Gizachew,McCarthy Michael P.,Cassatt David R.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference22 articles.

1. Amifostine

2. Amifostine: Mechanisms of Action Underlying Cytoprotection and Chemoprevention

3. New Dosing Regimens for Amifostine: A Pilot Study to Compare the Relative Bioavailability of Oral and Subcutaneous Administration with Intravenous Infusion

4. A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances of Amifostine in Radiation Protection: Administration and Delivery;Molecular Pharmaceutics;2023-09-25

2. Silver nanoparticles conjugated MnFe-based Prussian blue analogue for voltammetric and impedimetric bioaptasensing of amifostine (ethyol);Microchimica Acta;2020-09-25

3. Fluorometric determination of amifostine and alkaline phosphatase on amphiprotic molecularly imprinted silica crosslinked with binary functional silanes and carbon dots;Biosensors and Bioelectronics;2020-03

4. Dual mode detection of amifostine based on gold nanoparticles and sulfanilic acid functionalized graphene quantum dots;New Journal of Chemistry;2018

5. Long-term bioavailability of redox nanoparticles effectively reduces organ dysfunctions and death in whole-body irradiated mice;Biomaterials;2017-06